Following infection, SET2 cells were selected with puromycin for three days and re-plated at low density before initiating treatment with DMSO or JAK2 inhibitor at 0.2 and 0.35 μM, which are the IC25 and IC50 of SAR302503, respectively (Supplementary Fig.1). This evidence concerns the gene JAK2 and infection.